These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 11884204)
1. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Berglund MM; Saar K; Lundell I; Langel U; Larhammar D Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204 [TBL] [Abstract][Full Text] [Related]
2. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types. Kahl U; Langel U; Bartfai T; Grundemar L Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295 [TBL] [Abstract][Full Text] [Related]
3. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype. Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563 [TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of rabbit neuropeptide Y receptor subtypes. Umeda T; Kanatani A; Iwaasa H Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103 [TBL] [Abstract][Full Text] [Related]
6. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors. Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide. Saar K; Mahlapuu R; Laidmäe E; Valkna A; Kahl U; Karelson E; Langel U Regul Pept; 2001 Oct; 102(1):15-9. PubMed ID: 11600206 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369 [TBL] [Abstract][Full Text] [Related]
9. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Goumain M; Voisin T; Lorinet AM; Laburthe M Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the human neuropeptide Y Y2-receptor. Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911 [TBL] [Abstract][Full Text] [Related]
11. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist. Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors. Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. Cabrele C; Beck-Sickinger AG J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209 [TBL] [Abstract][Full Text] [Related]
14. Expression cloning of a human brain neuropeptide Y Y2 receptor. Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Beck-Sickinger AG; Jung G Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945 [TBL] [Abstract][Full Text] [Related]
16. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000 [TBL] [Abstract][Full Text] [Related]
17. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. Dumont Y; Jacques D; Bouchard P; Quirion R J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905 [TBL] [Abstract][Full Text] [Related]
18. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes. Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Gehlert DR; Schober DA; Morin M; Berglund MM Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631 [TBL] [Abstract][Full Text] [Related]
20. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype. Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]